ONS figures show rapid decrease in people with higher COVID-19 antibody figures
August 12, 2022Medical Communications
The amount of UK residents with higher levels of COVID-19 antibodies is falling, ONS statistics show.
Pfizer to buy Global Blood Therapeutics for $5.4bn
August 11, 2022Business Services
Pfizer Inc is to pay $5.4 billion in cash to acquire sickle cell disease drug-maker Global Blood Therapeutics, according to …
All children aged one to nine in London to be offered polio vaccine
August 11, 2022Business Services
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that a targeted inactivated polio vaccine (IPV) booster be given …
NHS backlog of 22,500 longest-wait patients slashed to fewer than 200, says NHS England figures
August 11, 2022Business Services
The COVID-19 pandemic caused a huge backlog in patients as medical services focused their efforts on combating the virus. At …
COVID-19 sewage surveillance labs join the hunt for monkeypox
August 11, 2022Business Services
Wastewater surveillance techniques are being adapted for use in monitoring the spread of monkeypox across the San Francisco Bay Area …
Study highlights major factors in shaping cross-disorder cortical abnormalities
August 10, 2022Research and Development
The study began by constructing maps of cortical abnormalities from thirteen neurodevelopmental, neurological, and psychiatric disorders. These maps came from …
Survey reveals 45% of junior doctors are considering leaving the profession
August 10, 2022Research and Development
1 in 3 (36%) of GPs and 1 in 4 (25%) of specialists surveyed were also looking to pursue a …
Karuna Therapeutics announces positive results from Phase III trial into schizophrenia
August 10, 2022Research and Development
Karuna Therapeutics has announced positive topline results from its Phase III EMERGENT-2 trial, evaluating the efficacy, safety, and tolerability of …
Tagrisso combined with Hutchmed drug clears lung cancer test
August 10, 2022Research and Development
Tagrisso and Hutchmed have revealed positive Phase II data on their combination drug, which prompts the two partners to progress …
US doctor warns of many undiagnosed polio cases
August 9, 2022Manufacturing and Production
A doctor in New York State has warned that there could be hundreds, or even thousands, of undiagnosed cases of …
FDA approves Myovant Sciences and Pfizer’s treatment for endometriosis pain
August 9, 2022Manufacturing and Production
The FDA has approved MYFEMBREE as a one-pill, once-a-day therapy for the management of moderate to severe pain associated with …
SMC accepts first licensed treatment for newly diagnosed AL amyloidosis
August 9, 2022Manufacturing and Production
The SMC has accepted the first licensed treatment for adults with newly diagnosed systemic light chain (AL) amyloidosis. Darzalex® (daratumumab) …
Patients’ cancers should be genetically profiled to improve care, health experts say
August 9, 2022Manufacturing and Production
A consensus group of leading experts have shared that the NHS should offer all cancer patients genetic profiling of their …
HUTCHMED’s metastatic colorectal cancer treatment meets primary endpoint in Phase III trial
August 8, 2022Sales and Marketing
HUTCHMED has announced that its global Phase III FRESCO-2 trial, evaluating the investigational use of fruquintinib, reached its primary endpoint …
Another “Winter crisis” on horizon for NHS without urgent action
August 8, 2022Sales and Marketing
The NHS in England could face “very serious challenges coming down the track” without significant action tackling the emergency crisis …
SIGA will seek FDA approval of monkeypox treatment once data is available
August 8, 2022Sales and Marketing
The CEO of SIGA Technologies has announced that they are planning to ask the FDA for approval and authorisation for …
Melanoma cells use ‘molecular drills’ to invade new tissues, research finds
August 8, 2022Sales and Marketing
Scientists have identified a nerve cell gene that enables melanoma cells to branch out and invade new tissues. Research from …
F2G announce development and commercialisation for rare antifungal treatment
August 5, 2022Medical Communications
F2G, a clinical-stage biopharmaceutical company, has announced that it can now soon bring a fourth antifungal class to the market. …
Societal CDMO wins tech transfer and production contract for HIV drug candidate
August 5, 2022Medical Communications
Societal CDMO, a contract development and manufacturing organisation (CDMO) has been selected to provide CDMO services to support the ongoing …
Over 100,000 monkeypox vaccines procured, according to government
August 4, 2022Business Services
Over 100,000 doses of the monkeypox vaccine have been acquired in order to combat the spread of the virus, the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
